Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • RESOURCES
    • About BJGP
    • Conference
    • Advertising
    • BJGP Life
    • eLetters
    • Librarian information
    • Alerts
    • Resilience
    • Video
    • Audio
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
    • RCGP e-Portfolio

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
Advertisement
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
    • RCGP e-Portfolio
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
Advertisement
British Journal of General Practice

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • RESOURCES
    • About BJGP
    • Conference
    • Advertising
    • BJGP Life
    • eLetters
    • Librarian information
    • Alerts
    • Resilience
    • Video
    • Audio
    • COVID-19 Clinical Solutions
Life & Times

Yonder: COVID non-compliance, antidepressant withdrawal, probiotics, and GPs in China

Ahmed Rashid
British Journal of General Practice 2021; 71 (703): 76. DOI: https://doi.org/10.3399/bjgp21X714785
Ahmed Rashid
UCL Medical School, UCL, London. Email: @Dr_A_Rashid
Roles: GP and Clinical Associate Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ahmed.rashid@ucl.ac.uk
  • Article
  • Figures & Data
  • Info
  • eLetters
  • PDF
Loading

Published eLetters

eLetter submission guidelines

Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Jump to comment:

  • Yonder: COVID non-compliance, antidepressant withdrawal, probiotics, and GPs in China
    Sian F. Gordon
    Published on: 07 March 2021
  • Published on: (7 March 2021)
    Yonder: COVID non-compliance, antidepressant withdrawal, probiotics, and GPs in China
    • Sian F. Gordon, GP and GP appraiser, Graeme Medical Centre, Falkirk

    It is disappointing that, in an issue of BJGP devoted to mental health, the only mention of the increasingly recognised problem of antidepressant dependence is in reference to an article published elsewhere.

    I have been in practice long enough to recall the Defeat Depression campaign of the 1990s. I recently came across some of the material distributed to GPs in support of this campaign,1 which was supported by both the RCPsych and RCGP, as well as the pharmaceutical industry. We were told that the then-new SSRIs were safe, effective and non-addictive, they corrected a chemical imbalance in the brain, and that GPs were massively under-recognising and undertreating depression. The professional consensus emerged that it was good practice to prescribe to anyone who had “biological symptoms of depression” for two weeks or more. The studies backing these assertions covered a standard 8 – 12 weeks.

    Now we are faced with huge prescription numbers, driven at least in part by long term prescribing, for which there is a very flimsy evidence-base. Many people have developed discontinuation symptoms when stopping these drugs, been told by their doctors that these represent a relapse of their original condition and can now count the years over which they have been dependent on prescribed drugs.

    The RCPsych has moved its position, as evidenced by its recent publication “Stopping antidepressants”,2 endorsed...

    Show More

    It is disappointing that, in an issue of BJGP devoted to mental health, the only mention of the increasingly recognised problem of antidepressant dependence is in reference to an article published elsewhere.

    I have been in practice long enough to recall the Defeat Depression campaign of the 1990s. I recently came across some of the material distributed to GPs in support of this campaign,1 which was supported by both the RCPsych and RCGP, as well as the pharmaceutical industry. We were told that the then-new SSRIs were safe, effective and non-addictive, they corrected a chemical imbalance in the brain, and that GPs were massively under-recognising and undertreating depression. The professional consensus emerged that it was good practice to prescribe to anyone who had “biological symptoms of depression” for two weeks or more. The studies backing these assertions covered a standard 8 – 12 weeks.

    Now we are faced with huge prescription numbers, driven at least in part by long term prescribing, for which there is a very flimsy evidence-base. Many people have developed discontinuation symptoms when stopping these drugs, been told by their doctors that these represent a relapse of their original condition and can now count the years over which they have been dependent on prescribed drugs.

    The RCPsych has moved its position, as evidenced by its recent publication “Stopping antidepressants”,2 endorsed by the RCGP. This is welcome after years of denial from both colleges that there was a significant problem with SSRI withdrawal. The recent past president of the RCPsych recently told Telegraph Magazine “that prescription figure is high. However, most antidepressants are started by GPs”.3

    This is important now. Not only are there large numbers of people who need help in coming off their medications, but we risk adding to their number if the stress and exhaustion of COVID-19 and its aftermath are also subjected to the seemingly irresistible pressure to medicalise human distress. General practice, and the RCGP in particular needs to resist the urge to defensiveness, learn the lessons of experience4 and show leadership in addressing this problem.

    References

    1. Pitt B. Down with gloom! Or how to defeat depression.  1993.  Publisher: Gaskell 
    2. Royal College of Psychiatrists. Stopping antidepressants. Available at: www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/stopping-antidepressants. 
    3. Levy M. The rise of 'McMeds': Are antidepressants becoming a fast fix? 2021.  The Telegraph.  Available at: www.telegraph.co.uk/health-fitness/mind/rise-mcmeds-antidepressants-becoming-fast-fix.
    4. The Independent Medicines and Medical Devices Safety Review.  First do no harm. 2020.  Available at: www.immdsreview.org.uk/Report.html. 

    Show Less
    Competing Interests: None declared.
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 71 (703)
British Journal of General Practice
Vol. 71, Issue 703
February 2021
  • Table of Contents
  • Index by author
Download PDF
Download PowerPoint
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Yonder: COVID non-compliance, antidepressant withdrawal, probiotics, and GPs in China
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Yonder: COVID non-compliance, antidepressant withdrawal, probiotics, and GPs in China
Ahmed Rashid
British Journal of General Practice 2021; 71 (703): 76. DOI: 10.3399/bjgp21X714785

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Yonder: COVID non-compliance, antidepressant withdrawal, probiotics, and GPs in China
Ahmed Rashid
British Journal of General Practice 2021; 71 (703): 76. DOI: 10.3399/bjgp21X714785
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • COVID non-compliance
    • Antidepressant withdrawal
    • Probiotics
    • GPs in China
    • Podcast of the month
    • REFERENCES
  • Figures & Data
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • Physical health checks for people with severe mental illness during COVID-19
  • Routine screening for domestic abuse
  • Books: Born to Run: the Hidden Tribe, the Ultra-Runners and the Greatest Race the World Has Never Seen
Show more Life & Times

Related Articles

Cited By...

Advertisement

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers
  • RCGP e-Portfolio

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7679
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2021 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242